SE
SENS
Senseonics Holdings, Inc.
$7.18
-2.05%
$300.1M
No data for this timeframe.
Vol
Market Cap$300.1M
Cap SizeSmall Cap
Analyst ConsensusBuy (69%)
Inst. Holders39 funds
Inst. Value$32.2M
Inst. Activity8 buys / 5 sells
Insider Activity3B / 0S
Insider Net $$326.1K
SEC Reports5
Press Releases3
Exchange Nasdaq·Sector Industrial Instruments For Measurement, Display, and Control·Inc. DE·CIK 0001616543·Prev Close $7.33
Recent Activity
Jun 6, 2026
Press
Senseonics presented positive real-world data at ADA 2026 showing Eversense 365 CGM delivers strong glucometrics and adh
Impact 4/10
Jun 6, 2026
fda
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
<p align="center"><em>Eversense 365 delivered favorable glucometrics compared to other open and clos
May 20, 2026
Insider
Steven Edelman was granted 9,852 shares
Director
May 20, 2026
Insider
ROEDER DOUGLAS A was granted 9,852 shares
Director
May 20, 2026
Insider
Larkin Sharon was granted 13,574 shares
Director
May 7, 2026
SEC
Senseonics reported Q1 2026 revenue of $11.7M (beat $9.8M consensus by 19.5%, up 87% YoY) with gross margin expanding to
PRESS-RELEASE — Impact 7/10
May 1, 2026
SEC
Senseonics is raising ~$74.7M in net proceeds via a dilutive offering of 8M shares and 8M pre-funded warrants at $5.00/s
424B5 — Impact 6/10
May 1, 2026
SEC
Senseonics announced it will release Q1 2026 financial results after market close on May 7, 2026. This is a routine sche
PRESS-RELEASE — Impact 1/10
Price Targets
$13.80
+92.2% upside
Strong Buy
Current $7.18
Low $8.00
Median $14.00
High $20.00
5 analysts
$8.00
$20.00
Analyst Ratings
2Strong Buy
7Buy
3Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 12, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| May 11, 2026 | Stifel | MAINTAIN | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.62 ▲ +4.6% | $-0.73 — $-0.50 | -55% YoY | 6 |
| Next Q | $-0.60 ▲ +6.2% | $-0.72 — $-0.46 | -40% YoY | 6 |
| Current FY | $-2.45 ▲ +1.8% | $-2.79 — $-2.09 | -48% YoY | 6 |
| Next FY | $-2.19 ▲ +10.9% | $-2.67 — $-1.88 | 11% YoY | 6 |
Latest Reports
NEUTRAL
Press
4/10
Senseonics presented positive real-world data at ADA 2026 showing Eversense 365 CGM delivers strong glucometrics and adh
Jun 6, 2026
BULLISH
PRESS-RELEASE
7/10
Senseonics reported Q1 2026 revenue of $11.7M (beat $9.8M consensus by 19.5%, up 87% YoY) with gross margin expanding to
May 7, 2026
BEARISH
424B5
6/10
Senseonics is raising ~$74.7M in net proceeds via a dilutive offering of 8M shares and 8M pre-funded warrants at $5.00/s
May 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $10.8M | — |
| BlackRock, Inc. | $3.8M | — |
| MARSHALL WACE, LLP | $3.1M | DOUBLED |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.5M | — |
| VANGUARD FIDUCIARY TRUST CO | $1.5M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Steven Edelman | A | $0.00 |
| May 20, 2026 | ROEDER DOUGLAS | A | $0.00 |
| May 20, 2026 | Larkin Sharon | A | $0.00 |
| May 20, 2026 | Prince Douglas | A | $0.00 |
| May 20, 2026 | DeFalco Stephen | A | $0.00 |
39 institutional holders with $32.2M total value (4,857,650 shares) as of 2026-Q1. Top holders: VANGUARD, BlackRock,, MARSHALL. Net buying activity: 8 institutions added/increased vs 5 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 1,617,197 | $10.8M | 33.4% | — |
| 2 | BlackRock, Inc. | 568,729 | $3.8M | 11.8% | — |
| 3 | MARSHALL WACE, LLP | 464,375 | $3.1M | 9.6% | DOUBLED +197.9% |
| 4 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 230,538 | $1.5M | 4.8% | — |
| 5 | VANGUARD FIDUCIARY TRUST CO | 225,167 | $1.5M | 4.7% | — |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 221,177 | $1.5M | 4.6% | — |
| 7 | Hood River Capital Management LLC | 186,426 | $1.2M | 3.9% | TRIM -55.7% |
| 8 | STATE STREET CORP | 180,281 | $1.2M | 3.7% | — |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 178,500 | $1.2M | 3.7% | — |
| 10 | GOLDMAN SACHS GROUP INC | 146,282 | $974.2K | 3.0% | — |
| 11 | MORGAN STANLEY | 123,943 | $825.5K | 2.6% | ADD +92.5% |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 116,500 | $775.9K | 2.4% | — |
| 13 | DEUTSCHE BANK AG\ | 84,177 | $560.6K | 1.7% | — |
| 14 | CITADEL ADVISORS LLC | 77,162 | $513.9K | 1.6% | — |
| 15 | BANK OF AMERICA CORP /DE/ | 56,964 | $379.4K | 1.2% | DOUBLED +126.8% |
| 16 | SEI INVESTMENTS CO | 49,592 | $330.3K | 1.0% | TRIM -52.0% |
| 17 | CITADEL ADVISORS LLC | 48,265 | $321.4K | 1.0% | — |
| 18 | Jain Global LLC | 35,926 | $239.3K | 0.7% | DOUBLED +125.6% |
| 19 | Brevan Howard Capital Management LP | 34,264 | $228.2K | 0.7% | — |
| 20 | OMERS ADMINISTRATION Corp | 31,000 | $206.5K | 0.6% | TRIM -45.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | DOUBLED | 155,905 | 464,375 | +197.9% | $3.1M | 2026-Q1 |
| Hood River Capital Management LLC | TRIM | 421,032 | 186,426 | -55.7% | $1.2M | 2026-Q1 |
| MORGAN STANLEY | ADD | 64,391 | 123,943 | +92.5% | $825.5K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 25,115 | 56,964 | +126.8% | $379.4K | 2026-Q1 |
| SEI INVESTMENTS CO | TRIM | 103,233 | 49,592 | -52.0% | $330.3K | 2026-Q1 |
| Jain Global LLC | DOUBLED | 15,926 | 35,926 | +125.6% | $239.3K | 2026-Q1 |
| OMERS ADMINISTRATION Corp | TRIM | 56,900 | 31,000 | -45.5% | $206.5K | 2026-Q1 |
| Hudson Bay Capital Management LP | ADD | 15,450 | 23,476 | +51.9% | $156.3K | 2026-Q1 |
| FMR LLC | DOUBLED | 603 | 14,736 | +2343.8% | $98.1K | 2026-Q1 |
| GROUP ONE TRADING LLC | ADD | 2,630 | 4,569 | +73.7% | $30.4K | 2026-Q1 |
| Allworth Financial LP | NEAR_EXIT | 1,446 | 201 | -86.1% | $1.3K | 2026-Q1 |
| CWM, LLC | ADD | 100 | 150 | +50.0% | $999.00 | 2026-Q1 |
| NATIONAL BANK OF CANADA /FI/ | TRIM | 275 | 100 | -63.6% | $661.00 | 2026-Q1 |
| VANGUARD GROUP INC | NEW | — | 1,833,224 | — | $10.1M | 2025-Q4 |
| Hood River Capital Management LLC | NEAR_EXIT | 8,554,118 | 421,032 | -95.1% | $2.3M | 2025-Q4 |
12 unique insiders with 36 transactions. Net insider value: $326.1K ($326.1K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Steven Edelman | Director | AWARD | 9,852 | — | — |
| May 20, 2026 | ROEDER DOUGLAS A | Director | AWARD | 9,852 | — | — |
| May 20, 2026 | Larkin Sharon | Director | AWARD | 13,574 | — | — |
| May 20, 2026 | Prince Douglas S | Director | AWARD | 9,852 | — | — |
| May 20, 2026 | DeFalco Stephen P | Director | AWARD | 9,852 | — | — |
| May 20, 2026 | DeFalco Stephen P | Director | AWARD | 13,574 | — | — |
| May 20, 2026 | Steven Edelman | Director | AWARD | 13,574 | — | — |
| May 20, 2026 | Fiorentino Edward | Director | AWARD | 13,574 | — | — |
| May 20, 2026 | Fiorentino Edward | Director | AWARD | 9,852 | — | — |
| May 20, 2026 | Prince Douglas S | Director | AWARD | 13,574 | — | — |
| May 20, 2026 | Larkin Sharon | Director | AWARD | 9,852 | — | — |
| May 20, 2026 | ROEDER DOUGLAS A | Director | AWARD | 13,574 | — | — |
| May 19, 2026 | Sullivan Frederick T. | Chief Financial Officer | AWARD | 124,193 | — | — |
| May 19, 2026 | HANSEN BRIAN B | Chief Commercial Officer | AWARD | 90,253 | — | — |
| May 19, 2026 | HANSEN BRIAN B | Chief Commercial Officer | AWARD | 124,193 | — | — |
| May 19, 2026 | Sullivan Frederick T. | Chief Financial Officer | AWARD | 90,253 | — | — |
| May 19, 2026 | Goodnow Timothy T | President and CEO | AWARD | 553,701 | — | — |
| May 19, 2026 | Goodnow Timothy T | President and CEO | AWARD | 761,923 | — | — |
| May 19, 2026 | Kaufman Francine | Chief Medical Officer | AWARD | 86,935 | — | — |
| May 19, 2026 | JAIN Mukul | Chief Operating Officer | AWARD | 270,759 | — | — |
| May 19, 2026 | JAIN Mukul | Chief Operating Officer | AWARD | 372,579 | — | — |
| May 19, 2026 | Horton Kenneth L | GC & Corp. Development Advisor | AWARD | 157,943 | — | — |
| May 19, 2026 | Horton Kenneth L | GC & Corp. Development Advisor | AWARD | 217,338 | — | — |
| May 19, 2026 | Kaufman Francine | Chief Medical Officer | AWARD | 63,177 | — | — |
| May 15, 2026 | Horton Kenneth L | GC & Corp. Development Advisor | TAX W/H | 7,320 | $5.82 | $42.6K |
| May 15, 2026 | Goodnow Timothy T | President and CEO | TAX W/H | 28,598 | $5.82 | $166.4K |
| May 15, 2026 | JAIN Mukul | Chief Operating Officer | TAX W/H | 13,681 | $5.82 | $79.6K |
| May 15, 2026 | Sullivan Frederick T. | Chief Financial Officer | TAX W/H | 9,005 | $5.82 | $52.4K |
| May 15, 2026 | Kaufman Francine | Chief Medical Officer | TAX W/H | 6,058 | $5.82 | $35.3K |
| May 12, 2026 | ROEDER DOUGLAS A | Director | BUY | 22,686 | $5.56 | $126.1K |
| Apr 1, 2026 | ROEDER DOUGLAS A | Director | AWARD | 2,218 | $6.65 | $14.7K |
| Apr 1, 2026 | Steven Edelman | Director | AWARD | 1,936 | $6.65 | $12.9K |
| Apr 1, 2026 | Fiorentino Edward | Director | AWARD | 2,124 | $6.65 | $14.1K |
| Apr 1, 2026 | Prince Douglas S | Director | AWARD | 1,221 | $6.65 | $8.1K |
| Mar 13, 2026 | Goodnow Timothy T | President and CEO | BUY | 17,225 | $5.79 | $99.7K |
| Mar 13, 2026 | ROEDER DOUGLAS A | Director | BUY | 17,500 | $5.73 | $100.3K |
5 SEC filing reports analyzed. Sentiment: 2 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.4/10.
BULLISH
PRESS-RELEASE
7/10
Senseonics reported Q1 2026 revenue of $11.7M (beat $9.8M consensus by 19.5%, up 87% YoY) with gross
May 7, 2026
BEARISH
424B5
6/10
Senseonics is raising ~$74.7M in net proceeds via a dilutive offering of 8M shares and 8M pre-funded
May 1, 2026
NEUTRAL
PRESS-RELEASE
1/10
Senseonics announced it will release Q1 2026 financial results after market close on May 7, 2026. Th
May 1, 2026
BEARISH
424B5
7/10
Senseonics Holdings is filing a preliminary prospectus supplement for an $80 million underwritten pu
Apr 30, 2026
BULLISH
CLUSTER
6/10
Senseonics CEO Timothy Goodnow and Director Douglas Roeder each purchased approximately $100,000 wor
Mar 16, 2026
NEUTRAL
4/10
Senseonics presented positive real-world data at ADA 2026 showing Eversense 365 CGM delivers strong
Jun 6, 2026
BEARISH
7/10
Senseonics priced an $80M underwritten public offering of 8M shares at $5.00/share plus 8M pre-funde
May 1, 2026
BULLISH
8/10
Senseonics reported strong Q4 and full-year 2025 revenue growth, with Q4 revenue up 72% YoY to $14.3
Mar 2, 2026
Current analyst consensus: Buy (69% buy). Based on 13 analysts: 2 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$13.80 mean target
+92.2% upside
Strong Buy (2.00)
$8.00 Low
$20.00 High
| Metric | Value |
|---|---|
| Current Price | $7.18 |
| Target Low | $8.00 |
| Target Mean | $13.80 |
| Target Median | $14.00 |
| Target High | $20.00 |
| # Analysts | 5 |
| Recommendation | Strong Buy (2.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.62 | $-0.73 | $-0.50 | -55.4% | +4.6% | 5↑ 1↓ | $0.0B | 94.0% | 6 |
| Next Q 2026-09-30 |
$-0.60 | $-0.72 | $-0.46 | -39.9% | +6.2% | 6↑ 0↓ | $0.0B | 92.9% | 6 |
| Current FY 2026-12-31 |
$-2.45 | $-2.79 | $-2.09 | -47.6% | +1.8% | 7↑ 0↓ | $0.1B | 76.4% | 6 |
| Next FY 2027-12-31 |
$-2.19 | $-2.67 | $-1.88 | 10.5% | +10.9% | 6↑ 1↓ | $0.1B | 57.5% | 6 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.622 | |
| 7d ago | $-0.622 | |
| 30d ago | $-0.652 | +0.030 |
| 60d ago | $-0.719 | +0.097 |
| 90d ago | $-0.719 | +0.097 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 12, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| May 11, 2026 | Stifel | MAINTAIN | Hold | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 7 | 3 | 1 | 0 | 69% | |
| May 1, 2026 | 2 | 8 | 3 | 1 | 0 | 71% | |
| Apr 1, 2026 | 2 | 8 | 3 | 1 | 0 | 71% | |
| Mar 1, 2026 | 2 | 8 | 3 | 1 | 0 | 71% | |
| Feb 1, 2026 | 2 | 8 | 3 | 1 | 0 | 71% | |
| Jan 1, 2026 | 2 | 8 | 3 | 1 | 0 | 71% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 6, 2026
fda
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
<p align="center"><em>Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s dif
Jun 1, 2026
other
Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026
<p align="justify">GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused
May 7, 2026
earnings
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
<p align="center"><em>Generated Q1 revenue of $11.7 million, an increase of 87% year-over-year</em></p>
May 6, 2026
short_volume
Short Volume: SENS — 59.6% short (0.5M / 0.8M)
Short: 472,540 | Exempt: 525 | TRF Vol: 792,418 | Short Ratio: 59.6% | Off-exchange volume (dark pool + OTC)
May 6, 2026
earnings_calendar
SENS Q1 2026 Earnings Scheduled — 2026-05-06
May 4, 2026
activist
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
<p>GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the design, d
May 1, 2026
earnings
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
<p align="justify">GERMANTOWN, Md., May 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused o
May 1, 2026
offering
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
<p>GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the develop
Apr 24, 2026
other
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
<p align="center"><em>The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks a
Mar 14, 2026
other
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
<p align="center"><em>New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adheren
Mar 2, 2026
earnings
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
<p align="center"><em>Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year</em></p>
Mar 2, 2026
earnings_calendar
SENS Q4 2025 Earnings After Market Close — 2026-03-02